Cal­i­for­nia stem cell clin­ic to pay out $3.65M set­tle­ment to for­mer pa­tients for in­ef­fec­tive treat­ments

Four years af­ter the FDA ad­mon­ished stem cell clin­ic Stem­Genex for mak­ing du­bi­ous claims about its ser­vices in treat­ing in­cur­able dis­eases, and 3 years af­ter …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER